- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/62 - DNA sequences coding for fusion proteins
Patent holdings for IPC class C12N 15/62
Total number of patents in this class: 10740
10-year publication summary
|
461
|
541
|
851
|
789
|
858
|
1014
|
1047
|
879
|
921
|
621
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20790 |
159 |
| The Trustees of the University of Pennsylvania | 4416 |
95 |
| President and Fellows of Harvard College | 6096 |
77 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3002 |
75 |
| The Board of Trustees of the Leland Stanford Junior University | 6668 |
65 |
| The Broad Institute, Inc. | 1979 |
60 |
| Regeneron Pharmaceuticals, Inc. | 4741 |
58 |
| The General Hospital Corporation | 4870 |
57 |
| Centre National de La Recherche Scientifique | 11042 |
43 |
| Sangamo Therapeutics, Inc. | 381 |
43 |
| The Johns Hopkins University | 5898 |
40 |
| Massachusetts Institute of Technology | 10259 |
39 |
| National Research Council of Canada | 1546 |
39 |
| Novartis AG | 10224 |
38 |
| F. Hoffmann-La Roche AG | 7816 |
37 |
| Board of Regents, The University of Texas System | 6127 |
35 |
| JCR Pharmaceuticals Co., Ltd. | 228 |
35 |
| Monsanto Technology LLC | 8580 |
34 |
| Cue Biopharma, Inc. | 207 |
34 |
| Memorial Sloan-Kettering Cancer Center | 2048 |
33 |
| Other owners | 9644 |